SCIASCIA THOMAS

CIK 00012299462 companiesNEW HAVEN, CT

SEC Profile

Transactions

Companies

Filings

CIK

0001229946

Recent Transactions

43 trades

Award
Trevi Therapeutics, Inc.$TRVI
Stock Option (right to buy)
2026-02-19+85,000→ 85,000 total
Award
Trevi Therapeutics, Inc.$TRVI
Performance Stock Option (right to buy)
2025-05-31+60,000→ 92,000 total
Exercise/Conversion
Trevi Therapeutics, Inc.$TRVI
Stock Option (right to buy)
2025-03-25−2,631→ 0 total
Exercise/Conversion
Trevi Therapeutics, Inc.$TRVI
Common Stock
2025-03-25$1.43/sh+2,631→ 224,004 total
Sale
Trevi Therapeutics, Inc.$TRVI
Common Stock
2025-03-25$6.60/sh−2,631→ 221,373 total
Award
Trevi Therapeutics, Inc.$TRVI
Performance Stock Option (right to buy)
2025-03-10+32,000→ 32,000 total
Award
Trevi Therapeutics, Inc.$TRVI
Stock Option (right to buy)
2025-02-18+116,000→ 116,000 total
Exercise/Conversion
Trevi Therapeutics, Inc.$TRVI
Common Stock
2024-08-19$1.43/sh+16,496→ 236,811 total
Sale
Trevi Therapeutics, Inc.$TRVI
Common Stock
2024-08-19$2.96/sh−16,496→ 220,315 total
Exercise/Conversion
Trevi Therapeutics, Inc.$TRVI
Stock Option (right to buy)
2024-08-19−16,496→ 0 total
Sale
Trevi Therapeutics, Inc.$TRVI
Common Stock
2024-08-16$2.76/sh−18,660→ 220,315 total
Exercise/Conversion
Trevi Therapeutics, Inc.$TRVI
Stock Option (right to buy)
2024-08-16−18,660→ 16,496 total
Exercise/Conversion
Trevi Therapeutics, Inc.$TRVI
Common Stock
2024-08-16$1.43/sh+18,660→ 238,975 total
Sale
Trevi Therapeutics, Inc.$TRVI
Common Stock
2024-08-15$2.79/sh−12,745→ 220,315 total
Exercise/Conversion
Trevi Therapeutics, Inc.$TRVI
Common Stock
2024-08-15$1.43/sh+12,745→ 233,060 total
Exercise/Conversion
Trevi Therapeutics, Inc.$TRVI
Stock Option (right to buy)
2024-08-15−12,745→ 35,156 total
Exercise/Conversion
Trevi Therapeutics, Inc.$TRVI
Stock Option (right to buy)
2024-08-14−100→ 47,901 total
Sale
Trevi Therapeutics, Inc.$TRVI
Common Stock
2024-08-14$2.75/sh−100→ 220,315 total
Exercise/Conversion
Trevi Therapeutics, Inc.$TRVI
Common Stock
2024-08-14$1.43/sh+100→ 220,415 total
Exercise/Conversion
Trevi Therapeutics, Inc.$TRVI
Common Stock
2024-05-29$2.19/sh+59,354→ 267,801 total
Sale
Trevi Therapeutics, Inc.$TRVI
Common Stock
2024-05-29$2.55/sh−53,368→ 214,433 total
Exercise/Conversion
Trevi Therapeutics, Inc.$TRVI
Stock Option (right to buy)
2024-05-29−59,354→ 0 total
Award
Trevi Therapeutics, Inc.$TRVI
Stock Option (right to buy)
2024-02-15+150,000→ 150,000 total
Award
Trevi Therapeutics, Inc.$TRVI
Stock Option (right to buy)
2023-02-16+187,500→ 187,500 total
Award
Trevi Therapeutics, Inc.$TRVI
Performance Stock Options (right to buy)
2022-09-19+7,500→ 37,500 total
Award
Trevi Therapeutics, Inc.$TRVI
Performance Stock Options (right to buy)
2022-06-29+30,000→ 30,000 total
Award
Trevi Therapeutics, Inc.$TRVI
Stock Option (right to buy)
2022-02-11+110,000→ 110,000 total
Award
Trevi Therapeutics, Inc.$TRVI
Stock Option (right to buy)
2022-02-11+110,000→ 110,000 total
Award
Trevi Therapeutics, Inc.$TRVI
Stock Option (right to buy)
2021-02-17+50,000→ 50,000 total
Award
Trevi Therapeutics, Inc.$TRVI
Stock Option (right to buy)
2020-02-13+60,000→ 60,000 total
Award
Trevi Therapeutics, Inc.$TRVI
Stock Option (right to buy)
2019-06-03+50,000→ 50,000 total
Conversion
Trevi Therapeutics, Inc.$TRVI
Series C Preferred Stock
2019-05-09−13,410→ 0 total
Conversion
Trevi Therapeutics, Inc.$TRVI
Common Stock
2019-05-09+17,118→ 193,724 total
Conversion
Trevi Therapeutics, Inc.$TRVI
Series A Preferred Stock
2019-05-09−109,015→ 0 total
Disposition from Tender
PENWEST PHARMACEUTICALS CO
Stock Option (Right-to-Buy)
2010-09-20$3.04/sh−75,000→ 0 total
Disposition from Tender
PENWEST PHARMACEUTICALS CO
Stock Option (right-to-Buy)
2010-09-20$2.62/sh−45,500→ 0 total
Disposition from Tender
PENWEST PHARMACEUTICALS CO
Stock Option (Right-to-Buy)
2010-09-20$3.05/sh−19,500→ 0 total
Disposition from Tender
PENWEST PHARMACEUTICALS CO
Common Stock
2010-09-20−40,494→ 0 total
Disposition from Tender
PENWEST PHARMACEUTICALS CO
Stock Option (Right-to-Buy)
2010-09-20$1.56/sh−65,000→ 0 total
Award
PENWEST PHARMACEUTICALS CO
Stock Option Right to Buy
2010-03-05+75,000→ 75,000 total
Award
PENWEST PHARMACEUTICALS CO
Stock Option Right-to-Buy
2009-03-05+65,000→ 65,000 total
Award
PENWEST PHARMACEUTICALS CO
Stock Option (Right-to-Buy)
2005-02-16$10.35/sh+35,000→ 35,000 total
Award
PENWEST PHARMACEUTICALS CO
Stock Option (Right-to_Buy)
2004-02-11$16.39/sh+30,000→ 30,000 total

Companies

Recent Filings

Address

C/O TREVI THERAPEUTICS, INC. 195 CHURCH STREET, 16TH FLOOR

NEW HAVEN, CT, 06510

View on SEC.gov